 |
|
|
|
 |
|
|
|
| Article 1 to 10 out of 323
|
|
-
Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics
(09 May 2008)
Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing
Microbix Biosystems Inc. announced that it intends to spin off its Urokinase assets into a new private company, Klarogen Biotherapeutics Inc., which would become the sole commercial-scale manufacturer and supplier of the clot-busting drug after ......
-
Genenews adds two members to its Board of Directors
(07 May 2008)
GeneNews Limited announced its shareholders recently elected two additional members to its Board of Directors, Mr. Harry A. Glorikian and Ms. Fran Tuttle. They join Mr. Rory Riggs, Mr. James Howard-Tripp, Mr. Garth MacRae, Dr. Heiner Dreismann, ......
-
Amorfix detects scrapie prions in blood from asymptomatic sheep
(05 May 2008)
Amorfix Life Sciences Ltd. announced the detection of endogenous prions in the blood plasma of asymptomatic scrapie infected sheep. The company had previously reported detecting symptomatic sheep which was a requirement for testing of human ......
-
MIGENIX Appoints Pieter Dorsman to Board of Directors
(24 Apr 2008)
MIGENIX Inc. has appointed Pieter Dorsman to its Board of Directors. Mr. Dorsman is President and a Director of Redpeaks Management, Inc., a financial consulting firm in Vancouver, which advises companies on finance and investment, corporate ......
-
Medicago completes cGMP qualification of its manufacturing facility
(22 Apr 2008)
Medicago Inc. announced that it has successfully completed the current Good Manufacturing Practices ("cGMP") qualification of its manufacturing facility located in the Technology Park of Québec City, Canada. cGMP rules and regulations governing ......
-
Protox announces positive long-term data from BPH study
(21 Apr 2008)
Protox Therapeutics Inc. announced positive results from its Phase 1 study evaluating PRX302 in patients with benign prostatic hyperplasia (BPH), a common and bothersome urological condition among the aging male population. The results indicate ......
-
Chemokine Therapeutics Announces New President And Chief Executive Officer
(18 Apr 2008)
Chemokine Therapeutics Corp. announced the appointment of Walter Korz as its new President and Chief Executive Officer (CEO). Mr. Korz succeeds Bashir Jaffer who held the position as Chief Executive Officer on an interim basis since December ......
-
Angiotech announces director resignation
(17 Apr 2008)
Angiotech Pharmaceuticals, Inc. announced the resignation of Greg Peet from his position as a non-executive director of the Company. Mr. Peet has resigned to enable him to focus on his numerous business pursuits and additional board ......
-
Vasogen Announces Implementation of Strategic Restructuring Plan
(16 Apr 2008)
Vasogen Inc. announced that it has implemented a strategic restructuring plan to significantly reduce its cash burn rate and focus its efforts on opportunities that the Board and management believe are most likely to provide long-term ......
-
AEterna Zentaris Announces Changes to its Management Team
(15 Apr 2008)
AEterna Zentaris Inc. announced that David J. Mazzo, Ph.D., has resigned as President and Chief Executive Officer and as member of the Board of Directors of AEterna Zentaris, effective immediately. Mr. Juergen Ernst, the current Chairman of the ......
|
|
|
Top